Correlation Between Biomarin Pharmaceutical and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Agios Pharm, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Agios Pharm.
Diversification Opportunities for Biomarin Pharmaceutical and Agios Pharm
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Biomarin and Agios is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Agios Pharm go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Agios Pharm
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Agios Pharm. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 1.73 times less risky than Agios Pharm. The stock trades about -0.14 of its potential returns per unit of risk. The Agios Pharm is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 4,473 in Agios Pharm on November 2, 2024 and sell it today you would lose (1,019) from holding Agios Pharm or give up 22.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Agios Pharm
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Agios Pharm |
Biomarin Pharmaceutical and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Agios Pharm
The main advantage of trading using opposite Biomarin Pharmaceutical and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Agios Pharm vs. Surrozen | Agios Pharm vs. Armata Pharmaceuticals | Agios Pharm vs. Pasithea Therapeutics Corp | Agios Pharm vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |